A Phase I Study To Evaluate The Safety Of Multiantigen Stimulated Tumor Specific Cell Therapy (Masct-I) In Subjects With Advanced Gastric Cancer.

JOURNAL OF CLINICAL ONCOLOGY(2021)

引用 1|浏览13
暂无评分
摘要
200Background: Gastric cancer was the fifth cancer world wide and the third leading cause of cancer-related death. PD-1 antibody has been approved for treatment in gastric cancer patients with posi...
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要